Transcription Factor for Killer Cell Activation, Differentiation and Uses Thereof
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jun 30, 2011
app pub date -
Dec 7, 2007
filing date -
Dec 7, 2006
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
The present invention provides methods for altering activation and/or differentiation of Killer cells comprising altering the expression of a Homologue Of Blimp-1 In T-cells (Hobit) species in said Killer-cells. The invention further provides methods and means for increasing or decreasing expression of a Hobit species in Killer cells, and provides isolated and/or recombinant nucleic acid and uses of said isolated and/or recombinant nucleic acid.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully